|05th December,2018||2:00-3:30 pm||Track 2|
Many universities and countries have created tech transfer financing tools which aim at partly de-risking assets of academic origin and commercializing them. Should investors in those financing tools be the least demanding and the most patient to make such tech transfer tools succeed in the long run?
Michael Motz - NETRIS Pharma
Yann Barrault - SATT Grand Centre